Articles Posted in Mass Torts

Our law firm is taking on new Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries in all 50 states.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

In many ways, 2023 was an anti-climatic year in the world of mass torts. The 3M Earplugs settlement has been a disappointment for thousands of claimants. The rejection of J&J’s efforts to force the talc claims into bankruptcy has not prompted a major settlement and the hernia mesh claims continue to drag on. We did get a major global settlement in the AFFF litigation, but it only covered water contamination claims by local municipalities.

Let’s talk about what we can expect in 2024 in the mass tort class action lawsuits with the highest predicted settlement payouts.

Camp Lejeune

Our firm’s national mass tort lawyers attorneys continuously monitor and track events in the various class action MDLs pending in the federal courts (MDL Docket #s). We track the volume of new cases being filed or transferred into each MDL every month, the trends or patterns in new case filings, and the status of bellwether trials, discovery, and other proceedings. And, of course, we track mass tort settlement amounts.

With a new year, we are starting to get a clearer picture of what we can expect in 2024 from the various mass tort MDLs, including those ready to grow and those ready to settle.

This post examines the hottest, biggest, and most compelling mass torts in 2024. If you click the individual links, we also project these settlement amounts.